225 related articles for article (PubMed ID: 34010654)
1. MeCP2 controls neural stem cell fate specification through miR-199a-mediated inhibition of BMP-Smad signaling.
Nakashima H; Tsujimura K; Irie K; Imamura T; Trujillo CA; Ishizu M; Uesaka M; Pan M; Noguchi H; Okada K; Aoyagi K; Andoh-Noda T; Okano H; Muotri AR; Nakashima K
Cell Rep; 2021 May; 35(7):109124. PubMed ID: 34010654
[TBL] [Abstract][Full Text] [Related]
2. miR-199a Links MeCP2 with mTOR Signaling and Its Dysregulation Leads to Rett Syndrome Phenotypes.
Tsujimura K; Irie K; Nakashima H; Egashira Y; Fukao Y; Fujiwara M; Itoh M; Uesaka M; Imamura T; Nakahata Y; Yamashita Y; Abe T; Takamori S; Nakashima K
Cell Rep; 2015 Sep; 12(11):1887-901. PubMed ID: 26344767
[TBL] [Abstract][Full Text] [Related]
3. MeCP2 dysfunction prevents proper BMP signaling and neural progenitor expansion in brain organoid.
Hong H; Yoon SB; Park JE; Lee JI; Kim HY; Nam HJ; Cho H
Ann Clin Transl Neurol; 2023 Jul; 10(7):1170-1185. PubMed ID: 37302988
[TBL] [Abstract][Full Text] [Related]
4. MeCP2-regulated miRNAs control early human neurogenesis through differential effects on ERK and AKT signaling.
Mellios N; Feldman DA; Sheridan SD; Ip JPK; Kwok S; Amoah SK; Rosen B; Rodriguez BA; Crawford B; Swaminathan R; Chou S; Li Y; Ziats M; Ernst C; Jaenisch R; Haggarty SJ; Sur M
Mol Psychiatry; 2018 Apr; 23(4):1051-1065. PubMed ID: 28439102
[TBL] [Abstract][Full Text] [Related]
5. Differentiation of multipotent neural stem cells derived from Rett syndrome patients is biased toward the astrocytic lineage.
Andoh-Noda T; Akamatsu W; Miyake K; Matsumoto T; Yamaguchi R; Sanosaka T; Okada Y; Kobayashi T; Ohyama M; Nakashima K; Kurosawa H; Kubota T; Okano H
Mol Brain; 2015 May; 8():31. PubMed ID: 26012557
[TBL] [Abstract][Full Text] [Related]
6. Graded and pan-neural disease phenotypes of Rett Syndrome linked with dosage of functional MeCP2.
Chen X; Han X; Blanchi B; Guan W; Ge W; Yu YC; Sun YE
Protein Cell; 2021 Aug; 12(8):639-652. PubMed ID: 32851591
[TBL] [Abstract][Full Text] [Related]
7. Role of DNA Methyl-CpG-Binding Protein MeCP2 in Rett Syndrome Pathobiology and Mechanism of Disease.
Pejhan S; Rastegar M
Biomolecules; 2021 Jan; 11(1):. PubMed ID: 33429932
[TBL] [Abstract][Full Text] [Related]
8. Inhibitors of differentiation (ID1, ID2, ID3 and ID4) genes are neuronal targets of MeCP2 that are elevated in Rett syndrome.
Peddada S; Yasui DH; LaSalle JM
Hum Mol Genet; 2006 Jun; 15(12):2003-14. PubMed ID: 16682435
[TBL] [Abstract][Full Text] [Related]
9. Modeling Rett Syndrome with Human Pluripotent Stem Cells: Mechanistic Outcomes and Future Clinical Perspectives.
Gomes AR; Fernandes TG; Cabral JMS; Diogo MM
Int J Mol Sci; 2021 Apr; 22(7):. PubMed ID: 33916879
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-197 controls ADAM10 expression to mediate MeCP2's role in the differentiation of neuronal progenitors.
Wang YM; Zheng YF; Yang SY; Yang ZM; Zhang LN; He YQ; Gong XH; Liu D; Finnell RH; Qiu ZL; Du YS; Wang HY
Cell Death Differ; 2019 Oct; 26(10):1863-1879. PubMed ID: 30560934
[TBL] [Abstract][Full Text] [Related]
11. CREB Signaling Is Involved in Rett Syndrome Pathogenesis.
Bu Q; Wang A; Hamzah H; Waldman A; Jiang K; Dong Q; Li R; Kim J; Turner D; Chang Q
J Neurosci; 2017 Mar; 37(13):3671-3685. PubMed ID: 28270572
[TBL] [Abstract][Full Text] [Related]
12. MeCP2 expression and function during brain development: implications for Rett syndrome's pathogenesis and clinical evolution.
Kaufmann WE; Johnston MV; Blue ME
Brain Dev; 2005 Nov; 27 Suppl 1():S77-S87. PubMed ID: 16182491
[TBL] [Abstract][Full Text] [Related]
13. Isolation of MECP2-null Rett Syndrome patient hiPS cells and isogenic controls through X-chromosome inactivation.
Cheung AY; Horvath LM; Grafodatskaya D; Pasceri P; Weksberg R; Hotta A; Carrel L; Ellis J
Hum Mol Genet; 2011 Jun; 20(11):2103-15. PubMed ID: 21372149
[TBL] [Abstract][Full Text] [Related]
14. PTP1B inhibition suggests a therapeutic strategy for Rett syndrome.
Krishnan N; Krishnan K; Connors CR; Choy MS; Page R; Peti W; Van Aelst L; Shea SD; Tonks NK
J Clin Invest; 2015 Aug; 125(8):3163-77. PubMed ID: 26214522
[TBL] [Abstract][Full Text] [Related]
15. Exploring the possible link between MeCP2 and oxidative stress in Rett syndrome.
Filosa S; Pecorelli A; D'Esposito M; Valacchi G; Hajek J
Free Radic Biol Med; 2015 Nov; 88(Pt A):81-90. PubMed ID: 25960047
[TBL] [Abstract][Full Text] [Related]
16. Neural development of methyl-CpG-binding protein 2 null embryonic stem cells: a system for studying Rett syndrome.
Okabe Y; Kusaga A; Takahashi T; Mitsumasu C; Murai Y; Tanaka E; Higashi H; Matsuishi T; Kosai K
Brain Res; 2010 Nov; 1360():17-27. PubMed ID: 20816763
[TBL] [Abstract][Full Text] [Related]
17. Differential brain region-specific expression of MeCP2 and BDNF in Rett Syndrome patients: a distinct grey-white matter variation.
Pejhan S; Siu VM; Ang LC; Del Bigio MR; Rastegar M
Neuropathol Appl Neurobiol; 2020 Dec; 46(7):735-750. PubMed ID: 32246495
[TBL] [Abstract][Full Text] [Related]
18. Disruption of MeCP2 attenuates circadian rhythm in CRISPR/Cas9-based Rett syndrome model mouse.
Tsuchiya Y; Minami Y; Umemura Y; Watanabe H; Ono D; Nakamura W; Takahashi T; Honma S; Kondoh G; Matsuishi T; Yagita K
Genes Cells; 2015 Dec; 20(12):992-1005. PubMed ID: 26456390
[TBL] [Abstract][Full Text] [Related]
19. MeCP2 binds to non-CG methylated DNA as neurons mature, influencing transcription and the timing of onset for Rett syndrome.
Chen L; Chen K; Lavery LA; Baker SA; Shaw CA; Li W; Zoghbi HY
Proc Natl Acad Sci U S A; 2015 Apr; 112(17):5509-14. PubMed ID: 25870282
[TBL] [Abstract][Full Text] [Related]
20. Regulation mechanism and research progress of MeCP2 in Rett syndrome.
Yang W; Pan H
Yi Chuan; 2014 Jul; 36(7):625-30. PubMed ID: 25076025
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]